CDKN2A and central nervous system neoplasm: Loss of function mutation of one or both gene products encoded by INK4a/ARF is a common mutation in human cancer, including glioma [44], and accordingly numerous investigators have utilized INK4a/ARF silencing mutations to create CNS neoplasms in mice.